1.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591

2.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

3.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997

4.

5.
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by van der Leeuw, Joep
Diabetologia, 2016-12, Vol.59 (12), p.2603–2612-2612

6.
Oral disease and cardiovascular disease in people with type 2 diabetes: prospective cohort study based on the ADVANCE trial
by Li, Qiang Qiang
Diabetologia, 2010-08-11, Vol.53 (11), p.2320-2327

7.
